Dynamic Mutation Profiles of SCLC Transformation in NSCLC Patients Harboring Concurrent EGFR/TP53/RB1 Mutations

被引：0
|
作者：
Huang, J. [1 ]
Huang, W. [2 ]
Wang, Q. [3 ]
Zhang, C. [1 ]
Ni, S. [4 ]
Sun, D. [4 ]
Zhou, Y. [4 ]
Hou, T. [4 ]
Sun, W. [4 ]
Chen, Z. [4 ]
Wu, Y. -L. [1 ]
机构：
[1] Guangdong Prov Peoples osp, Guangdong Lung Canc Inst, Guangzhou, Peoples R China
[2] Guangdong Prov Peoples Hosp, Guangdong Acad Med Sci, Dept Pathol, Guangzhou, Peoples R China
[3] Guangzhou Med Univ, Affiliated Canc Hosp & Inst, Guangzhou, Peoples R China
[4] Burning Rock Biotech, Guangzhou, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2022年 / 17卷 / 09期
关键词：
EGFR/TP53/RB1; CNV gain; decision tree;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MA02.05
引用
收藏
页码：S48 / S48
页数：1
相关论文
共 50 条
  • [31] Primary gefitinib resistance in NSCLC with EGFR combined RB1 mutation: a case report
    Ruan, Ming
    Ying, Haifeng
    Cui, Qiang
    Guo, Yuanbiao
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2019, 12 (07): : 9458 - 9462
  • [32] TUMOR-INFILTRATING LYMPHOCYTES IN GLIOBLASTOMA ARE ASSOCIATED WITH NF1, TP53, AND RB1 MUTATIONS AND THE MESENCHYMAL TRANSCRIPTIONAL SUBTYPE
    Rutledge, William C.
    Kong, Jun
    Gao, Jingjing
    Gutman, David A.
    Cooper, Lee A.
    Chisolm, Candace
    Scarpace, Lisa
    Mikkelsen, Tom
    Saltz, Joel H.
    Moreno, Carlos S.
    Brat, Daniel J.
    NEURO-ONCOLOGY, 2012, 14 : 41 - 41
  • [33] NGS Analysis Confirms Common TP53 and RB1 Mutations, and Suggests MYC Amplification in Ocular Adnexal Sebaceous Carcinomas
    Peterson, Cornelia
    Moore, Robert
    Hicks, Jessica L.
    Morsberger, Laura A.
    De Marzo, Angelo M.
    Zou, Ying
    Eberhart, Charles G.
    Campbell, Ashley A.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (16)
  • [34] A Tale of Concurrent Gene Mutations in EGFR and TP53 through a Next-Generation Sequencing Approach
    Gogte, P.
    Gurav, M.
    Joshi, P.
    Pai, T.
    Deshpande, G.
    Karnik, N.
    Shetty, O.
    Kaushal, R.
    Prabhash, K.
    Desai, S.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2022, 24 (10): : S104 - S104
  • [35] TP53 and RB1 alterations promote reprogramming and antiandrogen resistance in advanced prostate cancer
    Mu, Ping
    Cao, Zhen
    Hoover, Elizabeth
    Wongvipat, John
    Huang, Chun-Hao
    Karthaus, Wouter
    Abida, Wassim
    De Stanchina, Elise
    Sawyers, Charles
    CANCER RESEARCH, 2015, 75
  • [36] LSD1 is a targetable vulnerability in gastric cancer harboring TP53 frameshift mutations
    Wang, Suzeng
    Yang, Chunyu
    Tang, Junhui
    Wang, Kaiqing
    Cheng, Hao
    Yao, Surui
    Huang, Zhaohui
    Fei, Bojian
    CLINICAL EPIGENETICS, 2025, 17 (01)
  • [37] Tumor-Infiltrating Lymphocytes in Glioblastoma Are Associated with Mutations in NF1, RB1 and TP53 and Enriched in the Mesenchymal Transcriptional Class
    Brat, D.
    Rutledge, C.
    Kong, J.
    Gutman, D.
    Cooper, L.
    Appin, C.
    Chisolm, C.
    Park, Y.
    Scarpace, L.
    Mikkelsen, T.
    Moreno, C.
    Saltz, J.
    MODERN PATHOLOGY, 2013, 26 : 414A - 415A
  • [38] Tumor-Infiltrating Lymphocytes in Glioblastoma Are Associated with Mutations in NF1, RB1 and TP53 and Enriched in the Mesenchymal Transcriptional Class
    Brat, D.
    Rutledge, C.
    Kong, J.
    Gutman, D.
    Cooper, L.
    Appin, C.
    Chisolm, C.
    Park, Y.
    Scarpace, L.
    Mikkelsen, T.
    Moreno, C.
    Saltz, J.
    LABORATORY INVESTIGATION, 2013, 93 : 414A - 415A
  • [39] Histopathologic and Molecular Features of Lung Non-neuroendocrine Carcinomas with Co-inactivation Mutations of TP53 and RB1 Genes
    Zou, Sifan
    Sun, Tong
    Minerowicz, Christine
    Cai, Guoping
    Zhong, Minghao
    LABORATORY INVESTIGATION, 2023, 103 (03) : S1685 - S1686
  • [40] Evaluating RB1 and p53 as diagnostic markers in treatment-related neuroendocrine prostate cancer through immunohistochemistry and genomic analysis of RB1 and TP53
    Ueki, Hideto
    Jimbo, Naoe
    Terakawa, Tomoaki
    Hara, Takuto
    Tobe, Taisuke
    Hirata, Junichiro
    Wakita, Naoto
    Okamura, Yasuyoshi
    Suzuki, Kotaro
    Bando, Yukari
    Chiba, Koji
    Teishima, Jun
    Nakano, Yuzo
    Miyake, Hideaki
    PROSTATE, 2024, 84 (16): : 1506 - 1514
12345